Reports and Briefs on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Profitability Assessment of Branded Generic Inhalers

In this report, we provide a regulatory and economic analysis in Europe and the US of branded generic inhalers.

Published By Datamonitor
01 Jul 2015 $9500
Buy
Report
Report

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research.

Published By Datamonitor
15 Jun 2015 $7500
Buy
Report
Report

Forecast: Rheumatoid Arthritis in the US, Japan, and 5EU

Datamonitor Healthcare uses a patient-based approach to size the rheumatoid arthritis (RA) market in the US, Japan, and five major EU markets from 2014 to 2023, focusing on traditional and biologic disease-modifying therapies.

Published By Datamonitor
24 Apr 2015 $2800
Buy
Report
Report

Treatment: Rheumatoid Arthritis

Through our in-house primary research, Datamonitor Healthcare has produced thorough analysis on rheumatoid arthritis (RA) treatment trends, outcomes, and unmet needs.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Marketed Drugs: Rheumatoid Arthritis

Our marketed drugs analysis gives an overview of market behaviors as well as individual commercial and clinical attractiveness.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Pipeline: Rheumatoid Arthritis

Our pipeline product analysis gives an overview of how pipeline products in general are expected to perform, as well as early-phase projections and individual pipeline forecasts.

Published By Datamonitor
21 Apr 2015 $2800
Buy
Report
Report

Epidemiology of Hepatocellular Cancer in China

The size of HCC patient population in China provides a lucrative market for anti-cancer drugs. This epidemiologic analysis uses historical cancer incidence data to estimate and forecast HCC patient populations in China between 2012 and 2030.

Published By Datamonitor
25 Apr 2013 $2800
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
24 Apr 2013 $2000
Buy
Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $2800
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.